Skip to main content
Log in

Severe acute renal failure due to tubulointerstitial nephritis, pancreatitis, and hyperthyroidism in a patient during rifampicin therapy

  • Published:
Advances in Therapy Aims and scope Submit manuscript


It is well known that rifampicin can cause nephrotoxicity. Rifampicin-related pancreatitis and hyperthyroidism are rarely reported in the same patient in the presence of tubulointerstitial nephritis. Reported herein is the medical management of a patient with hemolytic anemia, acute renal failure, pancreatitis, and hyperthyroidism during with rifampicin therapy. A 50-year-old man was admitted to the hospital owing to abdominal colic and acute renal failure. He was treated with 2 courses of tetracycline-rifampicin for brucellosis 3 weeks and 4 months prior to admission. Physical examination showed blood pressure of 130/70 mm Hg, pulmonary crackles, and edema. Laboratory findings are detailed in the case report. Findings of abdominal ultrasonography suggested edematose pancreatitis and thyroid ultrasonography showed several solid nodules. Renal biopsy showed tubu-lointerstitial nephritis. Although rifampicin-related tubulointerstitial nephritis and acute renal failure are not uncommon during rifampicin therapy, the convergence of hyperthyroidism, pancreatitis, tubulointerstitial nephritis, and acute renal failure rarely presents in the same patient. Although pancreatitis, tubulointerstitial nephritis, and acute renal failure were ameliorated with corticoid therapy within 2 months, hyperthyroidism continued and required antithyroid therapy. In conclusion, rifampicin may trigger hyperthyroidism in patients with goiter.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others


  1. Rossert JA, Fischer EA. Acute interstitial nephritis. In: Johnson RJ, Feehally J, eds.Comprehensive Clinical Nephrology. 2nd ed. New York, NY: Mosby; 2003:769–791.

    Google Scholar 

  2. Chiristensen HR, Simonsen K, Hegedus L, et al. Influence of rifampicin on thyroid gland volume, thyroid hormones and antipyrine metabolism.Acta Endocrinol. 1989;121:406–410.

    Google Scholar 

  3. Wilmink T, Frick TW. Drug-induced pancreatitis.Drug Saf. 1996;14:406–423.

    Article  PubMed  CAS  Google Scholar 

  4. Muthukumar T, Jayakumar M, Fernando EM, Muthusethupathi MA. Acute renal failure due to rifampicin: a study of 25 patients.Am J Kidney Dis. 2002;40:690–696.

    Article  PubMed  CAS  Google Scholar 

  5. Parakash J, Kumar NS, Saxena RK, Verma U. Acute renal failure complicating rifampicin therapy.JAssoc Physicians India. 2001;49:877–880.

    Google Scholar 

  6. Liu BA, Knowles SR, Cohen LB, Werb MR, Shear NH. Pancreatic insufficiency due to antituberculous therapy.Ann Pharmacother. 1997;31:724–726.

    PubMed  CAS  Google Scholar 

  7. Ahrens N, Genth R, Salama A. Belated diagnosis in three patients with rifampicin-induced immune hemolytic anaemia.Br J Haematol. 2002;117:1–443.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations


Rights and permissions

Reprints and permissions

About this article

Cite this article

Paydas, S., Balal, M., Karayaylali, I. et al. Severe acute renal failure due to tubulointerstitial nephritis, pancreatitis, and hyperthyroidism in a patient during rifampicin therapy. Adv Therapy 22, 241–243 (2005).

Download citation

  • Issue Date:

  • DOI: